Current role
Biotechnology · Healthcare
Board Member
2024-01-01–present
Frederic Guerard
Board Member
LENZ Therapeutics, Inc. (LENZ)Equibles does not estimate personal net worth.
Get an email with a short summary when LENZ Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get LENZ alertsAbout Frederic Guerard
Frederic Guerard is recorded as Board Member at LENZ Therapeutics, Inc. (LENZ) since January 1, 2024. The newest filing on record that lists Frederic Guerard as Board Member at LENZ Therapeutics, Inc. (LENZ) is dated April 28, 2026. Frederic Guerard was last confirmed as Board Member at CalciMedica, Inc. (CALC) in a filing dated April 22, 2022. Earlier roles on record: CEO at CalciMedica, Inc. (CALC) until March 20, 2023. LENZ Therapeutics, Inc. reported in an 8-K filed March 22, 2024 that Frederic Guerard was appointed Class I director, effective March 21, 2024. CalciMedica, Inc. reported in an 8-K filed March 22, 2023 that Frederic Guerard was terminated as President and Chief Executive Officer. The proxy statement of CalciMedica, Inc. reports total compensation of $2,104,693 for Frederic Guerard in fiscal 2023, including a base salary of $239,138. Disclosed compensation is on record for 5 fiscal years. LENZ Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at LENZ Therapeutics, Inc. includes Daniel Chevallard (CEO and CFO), Kimberlee C. Drapkin (CEO, CFO, Chief Accounting Officer and Board Member), Jeff George (Chairman and Board Member) and 6 others.
“Effective as of the Effective Time, Frederic Guerard and James McCollum were appointed as Class I directors, Jeff George, Shelley Thunen, and Evert Schimmelpennink were appointed as Class II directors and Kimberlee C. Drapkin and Zach Scheiner were appointed as Class III directors.”
“(iii) each of Frederic Guerard, PharmD., Graybug's President and Chief Executive Officer, and Robert S. Breuil, Graybug's Chief Financial Officer, were terminated effective as of the effective time of the Merger.”
Affiliation history
-
Current
2024-01-01–present
Last confirmed April 28, 2026
-
Start not stated–2022-04-22
Last confirmed by a filing; no departure on record
-
Start not stated–2023-03-20
Company network
Leadership on record at LENZ Therapeutics, Inc.
- Daniel Chevallard CEO, CFO
- Kimberlee C. Drapkin CEO, CFO, Chief Accounting Officer, Board Member
- Jeff George Chairman, Board Member
- Mr. George Chairman
- Katherine V. Stultz COO
- Continuing Directors Board Member
- James McCollum Board Member
- Shelley Thunen Board Member
- Zach Scheiner Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | CalciMedica, Inc. (CALC) | Former Chief Executive Officer | $239,138 | $2,104,693 |
| 2022 | CalciMedica, Inc. (CALC) | Former Chief Executive Officer | $589,950 | $2,201,203 |
| 2021 | CalciMedica, Inc. (CALC) | Pharm.D. Chief Executive Officer | $570,000 | $4,405,460 |
| 2020 | CalciMedica, Inc. (CALC) | Chief Executive Officer | $511,813 | $4,221,840 |
| 2019 | CalciMedica, Inc. (CALC) | Chief Executive Officer | $433,617 | $989,223 |